4 directorsName hiddenVisible after signing in and 3 others
Documentsfilings and deeds
29-06-20261 day before the deadline
2025micro format
Gross margin from €401,156 to €545,694Result from €155,982 to €262,977Dividend €355,324Equity from €723,098 to €630,751Debts from €950,309 to €1.2mCash from €111,772 to €271,031
Higher net result than 93% of companies in human health. The sector median is €59,520, over 21,355 companies.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 17,816 companies had the same profile as NEURALGO has now. Each dot stands for 45 companies, two years later.
96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
Small
10 to 20 years old
solvency 30% or more
a profit of 5% of the balance sheet or more
Test of the method
The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 17,816 companies, not a prediction for NEURALGO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Environmental permit granted
Outbuildings · decided by Bruges
Company renamed from Dr.HANSSENS-Dr.VERMEERSCH to NEURALGOName after signing inVisible after signing in (manager) and Name hiddenVisible after signing in (manager) resign · Hidden nameVisible after signing in (director) and Name after signing inVisible after signing in (director) reappointed · General meeting of 29-11-2023 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0555873742
Environmental permit granted
Outbuildings, Outbuildings, Convert or extend · decided by Bruges
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as NEURALGO: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.6m and €2m, founded between 2012 and 2015.
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of NEURALGO?
NEURALGO is a private limited company (BV).
When was NEURALGO founded?
NEURALGO was founded on 19-06-2014.
Is NEURALGO still active?
Yes, NEURALGO is an active enterprise in the KBO register.
What is the turnover of NEURALGO?
The turnover in financial year 2025 is about €820,000. This figure is estimated from the gross margin of €545,694 and 31 comparable companies (NACE 86220). It probably lies between €730,000 and €1.1m.Financials
Is NEURALGO profitable?
In financial year 2025, NEURALGO made a profit of €262,977.
Where can I find the annual accounts of NEURALGO?
NEURALGO filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of NEURALGO due?
NEURALGO must file the annual accounts for financial year 2026 by 30-06-2027.Timeline